Northwestern Mutual Wealth Management’s Travere Therapeutics TVTX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.41K	Buy	+60	New	+$2.66K	﹤0.01%	3517
2025 Q3	–	Sell	-204	Closed	-$3.02K	–	4052
2025 Q2	$3.02K	Hold	204	–	–	﹤0.01%	3152
2025 Q1	$3.66K	Hold	204	–	–	﹤0.01%	3020
2024 Q4	$3.55K	Buy	+204	New	+$3.61K	﹤0.01%	3044
2024 Q2	–	Sell	-39	Closed	-$301	–	3827
2024 Q1	$301	Buy	+39	New	+$329	﹤0.01%	3360
2023 Q3	–	Sell	-45	Closed	-$691	–	3536
2023 Q2	$691	Buy	+45	New	+$819	﹤0.01%	3136
2017 Q1	–	Sell	-26	Closed	–	–	2401
2016 Q4	$0	Buy	+26	New	+$532	﹤0.01%	2510

Other funds holding TVTX

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northwestern Mutual Wealth Management's TVTX Position: Q2 2026 in Review

Northwestern Mutual Wealth Management opened a new position in Travere Therapeutics (TVTX) in Q2 2026: 60 shares worth $3.41K. The stake represents ﹤0.01% of the portfolio and ranks #3517 among its holdings. This is a return to the name: Northwestern Mutual Wealth Management previously reported a position in TVTX as recently as Q2 2025.

Northwestern Mutual Wealth Management first reported a position in TVTX in Q4 2016 and has held it in 7 quarters since. The position peaked at $3.66K in Q1 2025. 321 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

Northwestern Mutual Wealth Management held 60 shares of Travere Therapeutics worth $3.41K as of Q2 2026.
Travere Therapeutics was a new Northwestern Mutual Wealth Management position in Q2 2026.
Travere Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3517 holding.
Northwestern Mutual Wealth Management first reported a position in Travere Therapeutics in Q4 2016 and has held it in 7 quarters since.
Northwestern Mutual Wealth Management's Travere Therapeutics position peaked at $3.66K in Q1 2025.
321 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.